Working with colleagues in Cambridge University Hospitals we are merging chronobiology and pharmacogenomics to deliver Chrono-PGx.
Current projects include identifying pharmacogenomic variants that affect circadian regulatory cis-elements, and drugs that might benefit from seasonal dosing regimes.